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1. Materials and methods 
 
All the chemicals and solvents (spectroscopic grade) were purchased from Merck or Sigma and were used 
without any further purification. Reactions were monitored by thin layer chromatography using Merck TLC 
Silica gel 60 F254. Silica gel column chromatography was performed over Merck Silica gel 60 (particle size: 
0.040-0.063 mm, 230-400 mesh ASTM). 
1
H-NMR and 
13
C-NMR spectra were recorded on Bruker DPX-400 in 
CDCl3 solvent with tetramethylsilane as internal standard. All spectra were recorded at 25
o
C and coupling 
constants (J values) are given in Hz. Chemical shifts are given in parts per million (ppm). Mass spectra were 
recorded with Agilent Technologies 6224 TOF LC/MS and 6530 Accurate Mass Q-TOF LC/MS. 1,3-
Diphenylisobenzofuran was used as a singlet oxygen trap in organic solvent measurements and was purchased 
from supplier.  
The synthesis procedure of the upconverting nanoparticles as follows: In a 100 mL teflon beaker, 
rare-earth chloride salts YCl3.6H2O (0.72 mmol), YbCl3.6H2O (0.2 mmol), ErCl3.6 H2O (0.05 mmol), 
CeCl3.6H2O (0.03 mmol) and NaCl (1.0 mmol) were dissolved in 4.0 ml dd water. Polyethyleneimine 
(PEI, 1 g, MW: 10,000 g/mol) was dissolved in 20.0 ml dd. water and added to the solution of rare 
earth salts. NH4F (5 mmol) in 50 ml ethanol was added to the teflon beaker dropwise. After purging of 
air by bubbling Ar for 20 minutes, the reaction mixture was sealed and heated at 200
o 
C for 3 hours. 
The upconverting nanoparticles were collected by centrifuge at 10,000 rpm for 10 minutes. The 
nanoparticles were washed three times with ethanol/water (1:1) and dried in vacuo at 40°C. 
3 
 
 
        
 
 
Scheme S1 Synthetic routes for the carboxy-functionalized dyes: styryl-Bodipy 8, orthogonal Bodipy dimers 10, and 15. The 
numbering in the ESI is based on this scheme. 
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2. Synthesis of BODIPY photosentisizers 
 
The numbering of the compounds  in the ESI is based on the synthesis scheme on the previous page. 
 
2.a. Synthesis of BODIPY-8: p-Hydroxybenzaldehyde (1) (1000 mg, 8.18 mmol) was dissolved in acetonitrile 
(20 ml). K2CO3 (9.58 mg, 49.08 mmol) and a catalytic amount of benzo-18-crown-6 was added to the first 
solution. Into this solution, 6-bromohexaonic acid (2) ( 2.40 mg, 12.28 mmol) dissolved in asetonitril (15 ml) 
was added. Reaction mixture was refluxed overnight. Progress of the reaction was monitored by TLC. When all 
the starting material had been consumed, the reaction mixture was filtered  and washed with cold acetonitrile for 
two times. White crude was dissolved in dd water (15 ml) then neutralized with 4M HCl. White percipitates 
were filtered and dried. 6-(4-formylphenoxy)hexanoic acid (3) were obtained in 58% yield. 
1
H-NMR (400 MHz, 
CDCl3): δH 7.51 (d, 2H, J=8.4 Hz, Ar-CH), 6.70 (d, 2H, J=8.4 Hz, Ar-CH), 3.75 (t, 2H, J= 6.3 Hz, CH2), 2.01 (t, 
2H J= 7.2 Hz, CH2), 1.56-1.49 (m, 2H, CH2), 1.41-1.34 (m, 2H, CH2), 1.25-1.19 (m, 2H, CH2).  
13
C-NMR (100 
MHz, CDCl3): δC 195.1 (C=O), 176.5 (C=O), 166.0 (Cipso), 136.0 (CH), 130.0 (Cipso), 118.7 (CH), 72.0 (CH2), 
37.8 (CH2), 32.5 (CH2), 29.4 (CH2), 28.4 (CH2).  
 
In argon bubbled 250 mL dichloromethane, 6-(4-formylphenoxy)hexanoic acid (3) (700 mg, 2.96 mmol) and 
2,4-dimethylpyrrole (4) (564 mg, 5.92 mmol) were mixed. 1 drop of trifluoroacetic acid (TFA) was also added. 
The reaction mixture was stirred at room temperature overnight. Then p-chloranil (800 mg, 3.26 mmol) was 
added to the reaction medium. After stirring 5 hours at room temperature, TEA (triethylamine) (5 mL) and 
BF3.OEt2 (5 mL) was added and stirred again for further 1 hour. The reaction was stopped by extracting with 
water (3x250 mL). Organic phase was dired over Na2SO4 and evaporated. The crude was prufied by column 
chromatography with MeOH (3%)- CHCl3 yielded the orange product (5) (22 %). 
1
H-NMR (400 MHz, CDCl3): 
δH 7.16 (d, 2H, J=8.6 Hz, Ar-CH), 7.00 (d, 2H, J=8.6 Hz, Ar-CH), 5.99  (s, 2H, CH), 4.03 (t, 2H, J=6.4 Hz, 
CH2), 2.56 (s, 6H, CH3), 2.44 (t, 2H, J=7.4 Hz, CH2), 1.89-1.84 (m, 2H, CH2), 1.78-1.73 (m, 2H, CH2), 1.63-
1.57 (m, 2H, CH2), 1,45 (s, 6H, CH3).
 13
C-NMR (100 MHz, CDCl3): δC 179.0 (COOH), 159.6 (Cipso), 155.2 
(Cipso), 143.2 (Cipso), 141.9 (Cipso),131.9 (Cipso), 129.2 (CH), 127.0 (Cipso), 121.1 (CH), 115.1 (CH), 67.7 (CH2), 
33.9 (CH3), 28.9 (CH2), 25.6 (CH2), 24.5 (CH2) ve 14.6 (CH2). 
 
Compound 5 (500 mg, 1,1 mmol) was dissolved in  ethanol (200 ml). To this solution, iodide (586.30 mg, 2.31 
mmol) and HIO3 (iodic  asit) (483.8 mg, 2.75 mmol) were added, then heated at 60°C for1.5h. Progress of the 
reaction was monitored by TLC. When all the starting material had been consumed, the reaction was 
evaporated. The pink crude was dissolved in DCM then extracted with sodium thiosulphate saturated water (100 
mlx2). Organic phase was dired over Na2SO4 and evaporated. The crude was prufied by column 
chromatography using MeOH (3%)- CHCl3 solvent mixture yielded the pink product (6) (35 %). 
1
H-NMR (400 
MHz, CDCl3): δH 7.03 (d, 2H, J=8.4 Hz, Ar-CH), 6.93 (d, 2H, J=8.4 Hz, Ar-CH), 3.94 (t, 2H, J= 6.4 Hz, CH2), 
2.54 (s, 6H, CH3), 2.29 (t, 2H, J= 7.4 Hz, CH2), 1.81- 1.72 (m, 2H, CH2), 1.69-1.61 (m, 2H, CH2) ve 1.52- 1.50 
(m, 2H, CH2), 1.35 (s, 6H, CH3). 
13
C-NMR (100 MHz, CDCl3): δC 176.7 (COOH), 160.0 (Cipso), 156.5 (Cipso), 
145.4 (Cipso), 141.7 (Cipso),131.7 (Cipso), 129.0 (CH),  128.9 (Cipso), 126.5 (Cipso), 115.4 (CH), 67.9(CH2), 33.8 
(CH3), 28.9(CH2), 25.6(CH2), 25.0(CH2), 17.2 (CH3), 16.0(CH2). MS HRMS (TOF-APCI): m/z calcd for 
C25H27BF2I2N2O3: 705.0172 [M-H
+
]; found: 705.0111 [M-H
+
],  Δ = 8.6 ppm. 
 
In a 100 mL round-bottomed flask equipped with a Dean-Stark trap and a reflux condenser, 50 mL of benzene, 
compound 6 (238.2 mg, 0.34 mmol), 4-(N,N-dimetilamino)benzaldehit (7) (125.8 mg, 0.84 mg), acetic acid 
(AcOH) (0.5 ml, 7.4 mmol) and piperidine (0.5 ml, 5 mmol) were added. The reaction mixture was stirred at 
reflux temperature and concentrated nearly to dryness. Progress of the reaction was monitored by TLC. When 
all the starting material had been consumed, water (100 mL) was added and mixture was extracted into CHCl3. 
The organic layer was dried over Na2SO4 and evaporated. The crude was purified by column chromotography 
using MeOH (5%)- CHCl3 solvent mixture yielded the blue product (8) (12 %). 
1
H-NMR (400 MHz, CDCl3): δH 
8.15 (d, 1H, J= 16.7 Hz, CH), 7.50 (d, 2H, J= 8.6 Hz, Ar-CH),  7.45 (d, 1H, J= 16.7 Hz, CH), 7.09 (d, 2H, J= 
8.2 Hz, Ar-CH), 6.97  (d, 2H, J=8.2 Hz, Ar-CH), 6.68 ppm’de (d, 2H, J= 8.6 Hz, Ar-CH),  3.99 (t, 2H, J= 6.0 
Hz, CH2), 2.99 (s, 6H, CH3), 2.63 (s, 3H, CH3), 2.32-2.31 (m, 2H, CH2), 1.82-1.80 (m, 2H, CH2), 1.69-1.67 (m, 
2H, CH2), 1.54-1.52 (m, 2H, CH2), 1.40 (s, 3H, N-CH3) 1.45  (s, 3H, CH3). 
13
C-NMR (100 MHz, CDCl3): δC 
176.7 (COOH), 168.0 (Cipso), 159.9 (Cipso), 154.5 (Cipso), 151.0 (Cipso),142.1 (Cipso), 142.0 (CH) ,139.0 (CH), 
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129.5 (Cipso), 129.4 (Ar-CH), 129.3 (CH),  127.2 (Cipso), 115.3 (CH), 112.1 (CH), 67.8 (CH2), 40.3 (CH3), 
33.5(CH3), 31.6 (CH2), 28.9 (CH2), 25.6 (CH2) ve 24.5 (CH2), 17.8, 17.1 (CH3), 17.1(CH3). MS HRMS (TOF-
APCI): m/z calcd for C34H36BF2I2N3O3: 836.0907 [M-H
+
]; found: 836.0851[M-H
+
],  Δ = 6.7 ppm. 
 
2.b. Synthesis of BODIPY-10: In an oven dried 250 ml round bottom flask, POCl3 (10 ml, 100 mmol) and 
DMF (10 ml, 12 mmol) was stirred in ice bath under argon atmosphere for 15 minutes, then strirred further 30 
minutes at room temperature. Compound 5 (200 mg, 0.44 mmol) was dissolved in DCM (100ml) and added 
slowly to the first solution at room temperature.  After 3 hours stirring at room temperature, it was seen that the 
reaction has been finished by checking with TLC. Then, reaction mixture was poured into cold and saturated 
NaHCO3 solution slowly in ice-bath. The mixture was stirred for 30 minutes and extracted with DCM (100 
mlx3). Organic phase was dried over Na2SO4 and evaporated. The crude was purified by column 
chromotography using MeOH (1%)- CHCl3 solvent mixture yielded the orange product (9) (75 %).
1
H-NMR 
(400 MHz, CDCl3): δH 9.98 (s, 1H, -CHO), 7.12 (d, 2H, J=8.4 Hz, Ar-H), 7.01 (d, 2H, J=8.4 Hz, Ar-H), 6.13 (s, 
1H, CH), 4.02 (t, 2H, J=6.3 Hz CH2), 2.79 (s, 3H, CH3), 2.58 (s, 3H, CH3),  2.41 (t, 2H, J=7.3 Hz CH2),  1.87-
1.81 (m, 2H, CH2), 1.75-1.72 (m, 2H, CH2), 1.69 (s, 3H, CH3), 1.60-1.54 (m, 2H, CH2), 1.46 (s, 3H, CH3).
       
13
C-NMR (100 MHz, CDCl3): δC 186.1 (CHO), 179.2 (COOH), 160.0 (Ar-Cipso), 156.2 (Cipso), 147.1 (Ar-Cipso), 
142.7 (Cipso), 130.0 (Cipso), 128.9 (Ar-CH), 126.1 (Cipso), 123.8 (Cipso), 115.0 (Ar-CH), 68.2 (CH2), 34.1 (CH3), 
29.0 (CH2), 25.7 (CH2), 24.4 (CH2), 15.2(CH2), 13.1 (CH3), 11.9 (CH3). 
 
In argon bubbled 200 mL dichloromethane, compound 9 (173 mg, 0.36 mmol) and 2,4-dimethylpyrrole (4)  
(68.26 mg, 0.72 mmol) were mixed. 1 drop of trifluoroacetic acid was also added. The reaction mixture stirred 
at room temperature overnight. Then p-chloranil (97.36 mg, 0.396 mmol) was added to the reaction medium. 
After stirring 4 hours at room temperature, TEA (triethylamine) (2 mL) and BF3.OEt2 (2 mL) was added and 
stirred again for further 1 hour. The reaction was stopped by extracting with water (3x200 mL). Organic phase 
was dired over Na2SO4 and evaporated. The crude was prufied by column chromatography with MeOH (3%)- 
CHCl3 yielded the orange product (10) (32 %). 
1
H-NMR (400 MHz, CDCl3): δH 7.16 (d, 2H, J=8,4 Hz, Ar-H), 
7.00 (d, 2H, J=8,4 Hz, Ar-H), 6.07 (s, 1H, CH), 5.98 (s, 2H, CH), 4.00 (t, 2H, J=6,4 Hz, CH2), 2.59 (s, 3H, 
CH3), 2.53 (s, 6H, CH3), 2.41 (t, 2H, J=8,0 Hz, CH2), 2.34 (s, 3H, CH3), 1.88-1.81 (m, 2H, CH2), 1.77-1.73 (m, 
2H, CH2) 1.70 (s, 6H, CH3), 1.60-1.54 (m, 2H, CH2) 1.26 (s, 6H, CH3).  
13
C-NMR (100 MHz, CDCl3): δC 176,2 
(COOH), 159.8 (Ar-Cipso), 157.7 (Cipso), 155.1 (Cipso), 150.0 (Ar-Cipso), 145.9 (Cipso),  142.4 (Cipso),  133.8 (Cipso), 
131.0 (CH) , 130.0 (CH), 129.1 (Ar-CH), 126.5 (Cipso), 122.1 (Cipso), 121.2 (Cipso), 115.3 (Ar-CH), 67.8 (CH2), 
33.7 (CH3), 31.5 (CH3),  28.9 (CH2), 25.6 (CH2),  24.5 (CH2), 14.8 (CH2), 12.0 (CH3), 11.9 (CH3). MS HRMS 
(TOF-APCI): m/z calcd for C38H42B2F4I2N4O3: 699.3379 [M-H
-
],  ; found: 699.3307 [M-H
-
],  Δ = 10.3 ppm. 
 
2.c. Synthesis of BODIPY-15: In argon bubbled 200 mL dichloromethane, triethyl orthoformate  (11) (700 mg, 
4.73 mmol) and 2,4-dimethylpyrrole (4) (900 mg, 9.46 mmol) were mixed and stirred for 15 minutes. To this 
mixture, phosphoryl chloride (POCl3) (797.6 mg, 0,5 ml) was added and stirred further 2 hours. After stirring 2 
h. at room temperature, TEA (5 ml) and BF3.OEt2 (5 ml) was added and stirred again for further 1 hour. The 
reaction was stopped by extracting with water (3x200 mL). Organic phase was dired over Na2SO4 and 
evaporated. The crude was prufied by column chromatography with CHCl3 yielded the orange product (12)     
(67 %). 
1
H-NMR (400 MHz, CDCl3): δH 6.97 (s, 1H, Ar-CH), 5.97 (s, 2H, Ar-CH), 2.45 (s, 6H, CH3), 2.18 (s, 
6H, CH3); 
13
C-NMR (100 MHz, CDCl3): δC 156.8 (Cipso), 141.3 (Cipso), 133.5 (Cipso), 120.2 (CH), 119.1 (CH), 
14.8 (CH3), 11.2 (CH3). 
 
In an oven dried 250 ml round bottom flask, POCl3 (1 ml) and DMF (1 ml) was stirred in ice baht under argon 
atmosphere for 15 minutes, , then strirred further 30 minutes at room temperature. Compound 12 (621 mg, 2.5 
mmol)  was dissolved in DCM (100 ml) and added slowly to the first solution at room temperature.  After 4 
hours stirring at room temperature, when the reaction was checked by TLC, it was seen that the reaction has 
been finished. Then, reaction mixture was poured into cold and saturated NaHCO3 solution slowly in ice-bath. 
Mixture was stirred for 30 minutes and extracted with DCM (100 mlx3). Organic phase was dried over Na2SO4 
and evaporated. The crude was purified by column chromotography using CHCl3 solvent yielded the orange 
product (13) (78 %).
1
H-NMR (400 MHz, CDCl3): δH 9.99 (s, 1H, CHO), 7.17 (s, 1H, Ar-CH), 6.17 (s, 1H, Ar-
CH), 2.73 (s, 3H, CH3), 2.55 (s, 3H, CH3), 2.47 (s, 3H, CH3), 1.51 ppm (s, 3H, CH3). 
13
C-NMR (100 MHz, 
CDCl3): δC 185.5 (CHO), 163.5 (Cipso), 157.2 (Cipso), 145.4 (Cipso), 140.6 (Cipso), 136.4 (Cipso), 131.1 (Cipso), 125.8 
(Cipso), 122.0 (CH), 121.4 (CH), 15.2 (CH3), 12.7 (CH3), 11.5 (CH3), 10.4 (CH3). 
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In argon bubbled 200 mL dichloromethane, compound 13 (460 mg, 1.67 mmol)and 2,4-dimethylpyrrole (4)  
(313.67 mg, 3.33 mmol) were mixed. 1 drop of trifluoroacetic acid was also added. The reaction mixture stirred 
at room temperature overnight. Then p-chloranil (97.36 mg, 0.396 mmol) was added to the reaction medium. 
After stirring 4 hours at room temperature, TEA (triethylamine) (2 mL) and BF3.OEt2 (2 mL) was added and 
stirred again for further 1 hour. The reaction was stopped by extracting with water (3x200 mL). Organic phase 
was dired over Na2SO4 and evaporated. The crude was prufied by column chromatography with MeOH (3%)- 
CHCl3 yielded the orange product (14) (42 %). 
1
H-NMR (400 MHz, CDCl3): δH 7.16 (s, 1H, CH), 6.14 (s, 1H, 
CH), 6.01 (s, 2H, CH), 2.55 (s, 3H, CH3), 2.50 (s, 6H, CH3), 2.38 (s, 3H, CH3), 2.29 (s, 3H, CH3), 2.10 (s, 3H, 
CH3), 1.70 ppm (s, 6H, CH3). 
13
C-NMR (100 MHz, CDCl3): δC 160.3 (Cipso), 155.8 (Cipso), 151.5 (Cipso), 143.7 
(Cipso), 142.5 (Cipso), 136.6 (Cipso) , 134.7 (Cipso), 133.4 (Cipso), 132.3 (Cipso), 131.8 (Cipso) , 124.2 (C-H) , 121.3 
(C-H), 120.7 (C-H), 120.5 (C-H), 14.9 (CH3), 14.7 (CH3), 13.9 (CH3), 12.7 (CH3), 11.4 (CH3), 9.8 (CH3), 8.7 
(CH3). 
 
In a 50 ml round bottom flask, BODIPY 14 (97,24 mg, 0,2 mmol), acrylic acid (72.06 mg, 1 mmol) and            
t-buthlyperbenzoate (77.69 mg, 0.4 mmol) were dissolved in acetic acid: dioxane: DMSO (3:9:1) solvent 
system. To the reaction mixture, Pd(OAc)2 (8.98 mg, 0.04 mmol) catalyst was added under argon atmosphere. 
The reaction mixture was stirred at 35°C for 5 days. Progress of the reaction was checked by TLC. After 
compound 14 has been consumed, reaction was stopped. Reaction solvent was evaporated and purified by 
column chromatography with ethyl acetate yielded red compound (15) (20 %). 
1
H-NMR (400 MHz, CDCl3): δH 
7.79     (d, 1H, J= 16.0 Hz, CH), 7.33 (s, 1H, CH), 7.28 (s, 1H, CH), 6.29 (d, 1H, J= 16.0 Hz, CH), 6.06 (s, 1H, 
CH), 2.74 (s, 3H, CH3), 2.59 (s, 6H, CH3), 2.47 (s, 6H, CH3), 2.19 (s, 3H, CH3), 1.73 (s, 6H, CH3).
 13
C-NMR 
(100 MHz, CDCl3): δC 178.0 (COOH), 160.3 (Cipso), 156.3(Cipso),  152.3 (Cipso), 148.6 (Cipso), 137.3 (Cipso), 132.1 
(Cipso), 131.0 (Cipso), 130.4 (Cipso), 130.0 (CH), 128.7 (Cipso), 126.8 (Cipso), 125.2 (CH), 122.2 (CH), 121.6 (CH), 
121.5 (CH), 121.0 (Cipso), 116.4 (Cipso), 29.7 (CH3), 14.7 (CH3), 14.0 (CH3), 13.8 (CH3), 11.5 (CH3), 10.0 (CH3). 
MS HRMS (TOF-APCI): m/z calcd for C29H30B2F4I2N4O2: 563.2491 [M-H
-
],  ; found: 563.2385 [M-H
-
],  Δ = 
18.8 ppm. 
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3. 1H , 13C -NMR and Mass Spectra 
 
 
Fig. S1 
1
H-NMR spectrum of  the compound 3 (CDCl3,400 MHz) 
 
 
 
Fig. S2 
13
C-NMR spectrum of compound 3 (CDCl3, 100 MHz). 
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Fig. S3 
1
H-NMR spectrum of the compound 5 (CDCl3, 400 MHz) 
 
 
Fig. S4 
13
C-NMR spectrum of the compound 5 (CDCl3, 100 MHz) 
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Fig. S5  1H-NMR spectrum of the compound 6 (CDCl3, 400 MHz) 
 
 
Fig. S6 
13
C-NMR spectrum of the compound 6 (CDCl3, 100 MHz) 
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Fig. S7 HR- Mass spectrum of the compound 6 (m/z calcd for C25H27BF2I2N2O3: 705.0172 [M-H
+
]; found: 705.0111  
[M-H
+
],  Δ = 8.6 ppm.) 
 
 
Fig. S8  1H-NMR spectrum of the compound 8 (CDCl3, 400 MHz) 
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Fig. S9  13C-NMR spectrum of the compound 8 (CDCl3, 100 MHz) 
 
 
 
 
Fig. S10 HR- Mass spectrum of the compound 8 (m/z calcd for C34H36BF2I2N3O3: 836.0907 [M-H
+
]; found: 836.0851[M-
H
+
],  Δ = 6.7 ppm. 
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Fig. S11  1H-NMR spectrum of the compound 9 (CDCl3, 400 MHz) 
 
 
Fig. S12  13H-NMR spectrum of the compound 9 (CDCl3, 100 MHz) 
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Fig. S13  1H-NMR spectrum of the compound 10 (CDCl3, 400 MHz) 
 
 
Fig. S14 
13
C-NMR spectrum of the compound 10 (CDCl3, 400 MHz) 
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Fig. S15 HR- Mass spectrum of the compound 10 (m/z calcd for C38H42B2F4I2N4O3: 699,3379 [M-H
-
],  ; found: 699,3307 
[M-H
-
],  Δ = 10.3 ppm.) 
 
 
Fig. S16  
1
H-NMR spectrum of the compound 12 (CDCl3, 400 MHz) 
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Fig. S17 
13
C-NMR spectrum of the compound 12 (CDCl3, 100 MHz) 
 
  
Fig. S18 
1
H-NMR spectrum of the compound 13 (CDCl3, 400 MHz) 
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Fig. S19 
13
C-NMR spectrum of the compound 13 (CDCl3, 100 MHz) 
 
 
Fig. S20  
1
H-NMR spectrum of the compound 14 (CDCl3, 400 MHz) 
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Fig. S21  
13
C-NMR spectrum of the compound 14 (CDCl3, 100 MHz) 
 
Fig. S22   
1
H-NMR spectrum of the compound 15 (CDCl3, 400 MHz) 
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Fig. S23  
13
C-NMR spectrum of the compound 15 (CDCl3, 100 MHz) 
 
 
 
 
Fig. S24  HR- Mass spectrum of the compound 15 (m/z calcd for C29H30B2F4I2N4O2: 563.2491 [M-H
-
];  
found: 563.2385 [M-H
-
],  Δ = 18.8 ppm.) 
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4. Characterization of upconverting nanoparticles 
 
 
 
 
Fig. S25 X-ray Diffraction (XRD) pattern of PEI coated UCNP (NaYF4: Yb
+3
, Er
+3
/ Ce
+3 
 ) h: hexagonal, c:cubic phase 
peaks 
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Fig. S26  X-ray photoelectron spectrum (XPS) of PEI coated UCNP (NaYF4: Yb
+3
, Er
+3
/ Ce
+3  
(72: 20: 5:3 %).  
Peak at 402 eV belongs to nitrogen atom which means that PEI was coated on the UCNP. 
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Fig. S27  FTIR spectrum of (a) PEI covered UCNP, (b)BOD8-UCNP, (c)BOD10-UCNP, (d)BOD15-UCNP 
 
 
 
 
Fig.  S28 Room temperature upconversion emission spectra of the NaYF4: Yb, Er/Ce (72:20:5:3 mol %). 
Inset confocal picture was a photo from raman microscope showing the upconversion luminescence  
excited by 980 nm laser (50 mW) 
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5.  Singlet oxygen measurements of BODIPY conjugated upconversion nanoparticles 
 
                          
980 nm
  laser
3O2
1O2
UC-RET (550-660 nm)
NaYF4:Yb+3,
  Er+3/Ce+3
UCNP
 
 
                     Fig. S29   Schematic illustration of BODIPY-conjugated UCNP 
 
 
                                
 
Fig. S30 
1
O2 generation from BOD-8@ UCNP under 980 nm laser 
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Fig. S31 
1
O2 generation from BOD-10 @ UCNP under 980 nm laser 
 
 
 
 
 
Fig. S32  
1
O2 generation from BOD-15 @ UCNP under 980 nm laser 
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Control experiments 
 
 
 
 
Fig. S33 Control experiment-1: upconverting nanoparticles solution (0.4 mg/ml) without BODIPY dye in trap solution 
 
 
 
 
Fig. S34 Control experiment-2: BODIPY dyes in the presence of DPBF trap molecule under 980 nm laser light  
24 
 
 
 
Fig. S35 Singlet oxygen measurements of BODIPY dyes in the presence of DPBF trap molecule under laser light (610nm 
for BOD 8 and 520 nm for BOD10 and BOD15) 
 
 
 
Fig. S36 Equations from the plot (Fig.4) of exponential fit for BOD 8 and BOD10 (a and b) and lineer fit for BOD15. 
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Fig S37.  Synthetic procedure for the BODIPY conjugated upconverting nanoparticles. 
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Fig. S38 Overlaid emission spectra of  PEI-coated NaYF4:(Yb
+3
,Er
+3
)/Ce
+3
 UCNPs (black line) and absorption spectra of 
BOD-8, BOD-10 and BOD-15, respectively. 
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Fig. S39 Changes in the absorption spectrum of the selective singlet oxygen trap  
1,3-diphenyl-isobenzofuran (DPBF) in the presence of BODIPY-UCNP (0.4 mg/ml) 
 in methanol solution. Reactions were done in triplicate. 
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